What is Anzupgo 20 mg/g, Creme used for?

( ARTG ) ANZUPGO is indicated for the treatment of moderate to severe chronic hand eczema (CHE) in adults for whom topical corticosteroids are inadequate or inappropriate.

What are the side effects of Anzupgo 20 mg/g, Creme?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can Anzupgo 20 mg/g, Creme be used during pregnancy?

( AHT ) For the active ingredient delgocitinib You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Anzupgo 20 mg/g, Creme belong to?

Anzupgo 20 mg/g, Creme: ATC D11AH11. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Anzupgo 20 mg/g, Creme

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Leo Pharmaceutical Products Sarath Ltd. (CH)

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.